Publications

Filter Year

Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
Brandis JEP, Kihn KC, Taraban MB, Schnorr J, Confer AM, Batelu S, Sun D, Rodriguez JD, Jiang W, Goldberg DP, et al. 2021. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate. Molecular pharmaceutics 18(4): 1544-1557. DOI: 10.1021/acs.molpharmaceut.0c00922
Structural and biochemical insights into flavivirus proteins.
Dey D, Poudyal S, Rehman A, Hasan SS. 2021. Structural and biochemical insights into flavivirus proteins. Virus research 296: 198343. DOI: 10.1016/j.virusres.2021.198343
Overexpression of two CDPKs from wild Chinese grapevine enhances powdery mildew resistance in Vitis vinifera and Arabidopsis.
Hu Y, Cheng Y, Yu X, Liu J, Yang L, Gao Y, Ke G, Zhou M, Mu B, Xiao S, et al. 2021. Overexpression of two CDPKs from wild Chinese grapevine enhances powdery mildew resistance in Vitis vinifera and Arabidopsis. The New phytologist 230(5): 2029-2046. DOI: 10.1111/nph.17285
Intracellular Delivery of Active Proteins by Polyphosphazene Polymers.
Qamar B, Solomon M, Marin A, Fuerst TR, Andrianov AK, Muro S. 2021. Intracellular Delivery of Active Proteins by Polyphosphazene Polymers. Pharmaceutics 13(2): . DOI: 10.3390/pharmaceutics13020249
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.
Valencia SM, Zacharia A, Marin A, Matthews RL, Wu CK, Myers B, Sanders C, Difilippantonio S, Kirnbauer R, Roden RB, et al. 2021. Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP. Human vaccines & immunotherapeutics 17(8): 2748-2761. DOI: 10.1080/21645515.2021.1875763
Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics.
Yu YB, Briggs KT, Taraban MB, Brinson RG, Marino JP. 2021. Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics. Pharmaceutical research 38(1): 3-7. DOI: 10.1007/s11095-021-03008-w
Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.
Wang Y, Howell KA, Brannan J, Agans KN, Turner HL, Wirchnianski AS, Kailasan S, Fusco M, Galkin A, Chiang CI, et al. 2021. Prominent Neutralizing Antibody Response Targeting the <i>Ebolavirus</i> Glycoprotein Subunit Interface Elicited by Immunization. Journal of virology : . DOI: 10.1128/JVI.01907-20
An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.
Guest JD, Vreven T, Zhou J, Moal I, Jeliazkov JR, Gray JJ, Weng Z, Pierce BG. 2021. An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants. Structure (London, England : 1993) 29(6): 606-621.e5. DOI: 10.1016/j.str.2021.01.005
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.
Amcheslavsky A, Wallace AL, Ejemel M, Li Q, McMahon CT, Stoppato M, Giuntini S, Schiller ZA, Pondish JR, Toomey JR, et al. 2021. Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design. Scientific reports 11(1): 2751. DOI: 10.1038/s41598-021-81895-0
Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectives.
Linden SB, Alreja AB, Nelson DC. 2021. Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectives. Current opinion in biotechnology 68: 213-220. DOI: 10.1016/j.copbio.2021.01.012
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.
Marin A, Chowdhury A, Valencia SM, Zacharia A, Kirnbauer R, Roden RBS, Pinto LA, Shoemaker RH, Marshall JD, Andrianov AK. 2021. Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine. Nanomedicine : nanotechnology, biology, and medicine 33: 102359. DOI: 10.1016/j.nano.2021.102359
Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS).
Young BD, Yu W, Rodríguez DJV, Varney KM, MacKerell AD, Weber DJ. 2021. Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS). Molecules (Basel, Switzerland) 26(2): . DOI: 10.3390/molecules26020381
Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae.
Parvaiz N, Ahmad F, Yu W, MacKerell AD, Azam SS. 2021. Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae. PloS one 16(1): e0244967. DOI: 10.1371/journal.pone.0244967
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
Guest JD, Wang R, Elkholy KH, Chagas A, Chao KL, Cleveland TE, Kim YC, Keck ZY, Marin A, Yunus AS, et al. 2021. Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer. Proceedings of the National Academy of Sciences of the United States of America 118(3): . DOI: 10.1073/pnas.2015149118
Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.
Borkotoky S, Dey D, Banerjee M. 2021. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion. Journal of chemical information and modeling 61(1): 423-431. DOI: 10.1021/acs.jcim.0c01231